-
Loading metrics
Evaluation of In Vitro Activity of the Class I PI3K Inhibitor Buparlisib (BKM120) in Pediatric Bone and Soft Tissue Sarcomas
- Jennifer L. Anderson,
- Ann Park,
- Ryan Akiyama,
- William D. Tap,
- Christopher T. Denny,
- Noah Federman
x
- Published: September 24, 2015
- https://doi.org/10.1371/journal.pone.0133610